Trial Profile
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms TKRPROVTE
- 17 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Oct 2014 New trial record